TGFB1 and colon carcinoma: In addition, in the colon carcinoma Caco-2 cell line, which endogenously expresses the Smad4N351H mutation and is refractory to TGF-β treatment, TGF-β signaling can be restored by simply treating cells with the GSK3 inhibitor lithium chloride (LiCl).